Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Harnessing invariant natural killer T cells to control pathological inflammation

Frontiers in Immunology(2022)10.3389/fimmu.2022.998378Source: DataRank Database

Harnessing invariant natural killer T cells to control pathological inflammation is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (30)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Jenny E. Gumperz ORCID,Nikhila S. Bharadwaj ORCID

Live enrichment

PubMed:36189224 PMC:PMC9519390

NIAID NIH HHS

Grant: R21 AI159042

NIAID NIH HHS

Grant: R01 AI136500

National Institutes of Health

Grant: 5R01AI136500-03

Mechanisms of iNKT cell anti-viral adjuvancy

National Institute of Allergy and Infectious Diseases

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.998378/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.998378/full

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9519390

repositoryhttps://doaj.org/article/ca016d04d85c49ae9a399b0c5a20e6ec

Europe_PMChttps://europepmc.org/articles/PMC9519390

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsHumansMiceInflammationReceptors, Antigen, T-CellCytokinesLymphocyte ActivationAntigens, CD1dNatural Killer T-Cells

Keywords

ImmunotherapyAnti-inflammatoryImmunomodulatoryCd1dInkt CellImmuno-regulatoryInflammationImmunologyReceptors, Antigen, T-CellRC581-607Lymphocyte ActivationMiceAnimalsCytokinesHumansNatural Killer T-CellsImmunologic diseases. AllergyAntigens, CD1d

Sustainable Development Goals

SDG 3: 3. Good health